نتائج البحث 311-320 من 18894 لعملية البحث عن Two-phase
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...
This phase II trial tests whether an exercise ... This study consists of two parts to explore BGB-16673 recommended dosing: a part 1 monotherapy dose finding and ...
... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti-tumor activity. Patient Outcomes after Hepatic Artery Infusion Pump Placement.
BiCaZO: A Study Combining Two Immunotherapies ... (Stage I and Stage II). Additinoally, to ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.